Redmile Group’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Sell |
|
|||||
|
2025
Q1 | $2.77M | Sell |
|
|||||
|
2024
Q4 | $38.1M | Sell |
|
|||||
|
2024
Q3 | $35.8M | Sell |
|
|||||
|
2024
Q2 | $34.5M | Buy |
|
|||||
|
2024
Q1 | $46.1M | Buy |
|
|||||
|
2023
Q4 | $48.8M | Buy |
|
|||||
|
2023
Q3 | $46.4M | Hold |
|
|||||
|
2023
Q2 | $48.5M | Sell |
|
|||||
|
2023
Q1 | $77.8M | Sell |
|
|||||
|
2022
Q4 | $75M | Sell |
|
|||||
|
2022
Q3 | $94.2M | Buy |
|
|||||
|
2022
Q2 | $24.6M | Sell |
|
|||||
|
2022
Q1 | $21.6M | Sell |
|
|||||
|
2021
Q4 | $41.6M | Hold |
|
|||||
|
2021
Q3 | $52M | Sell |
|
|||||
|
2021
Q2 | $91.9M | Sell |
|
|||||
|
2021
Q1 | $126M | Sell |
|
|||||
|
2020
Q4 | $77M | Sell |
|
|||||
|
2020
Q3 | $76.8M | Sell |
|
|||||
|
2020
Q2 | $111M | Buy |
|